Cipla appoints Prabhakaran Nair as Global Chief Manufacturing Officer
Nair to take charge from July 1, 2025; joins Cipla’s senior management with focus on global manufacturing and compliance
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy…
Cipla receives US FDA approval for generic version of Abraxane
Cipla secures final USFDA approval for Protein-bound Paclitaxel 100 mg/vial; launch planned in H1 FY26 in the US market
Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension
This partnership aims to enhance ophthalmic care by providing treatment for post- operative inflammation and pain in patients…
AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma…
Ramandeep Singh, Vice President, Life Sciences and Healthcare, India, Clarivate, discusses the latest innovative R&D,…
Being complacent in pharma quality: Five minutes to midnight
Dr Sumedha Nadkar, Pharma Consultant and Visiting Faculty, shares a hard-hitting article which highlights that complacency in…
The 6th X-CIPLOG reunion event 2025 was held in Mumbai
X-CIPLOG Reunion 2025 and Excellence Awards reflect industry recognition resonating with the government’s padma bhushan honour to…
Cipla launches CipAir App for asthma screening in India
CipAir provides AI-driven asthma screening, enabling timely diagnosis and better respiratory care
Cipla’s manufacturing facility in Goa gets VAI classification
The US FDA conducted a cGMP inspection between June 10-21, 2024
MK Hamied, Vice Chairman and Non-Executive Director, Cipla steps down
Cipla announces appointment of Kamil Hamied as Non-Executive Director